NIH Patents and Patent Applications

This list includes non-provisional and PCT patent filings.

CSV download of the complete patent data set.

For information on patent application codes, country codes, and patent status, see the Patents FAQ.

Tips:
Reset the Search Filters to go back to the initial display of all records.
Sort columns by clicking on the blue column headers.
The Search function searches across all columns.
To filter results by Lead IC, Country, or Application, type or use the dropdown menu.

Lead IC Reference Number Title Country Patent Application Type Application Number Date Filed Patent Number Date Issued Patent Status Patent PDF
NCI E-176-2014-0-AU-58 Anti-Human Papillomavirus 16 E7 T Cell Receptors AU DIV 2021202227 Issued
NCI E-205-2010-2-JP-21 Photosensitizing Antibody-Flurophore Conjugates JP DIV 2021-67756 Abandoned
NCI E-121-2020-2-PCT-01 HLA CLASS I-RESTRICTED T CELL RECEPTORS AGAINST LMP2 PCT PCT COMB PCT/US2021/026883 Expired
NCATS E-022-2018-0-US-03 COMPOSITIONS AND METHODS FOR CELL CULTURE US National Stage 17/284,215 Pending
NCI E-040-2012-0-AU-63 Chimeric Antigen Receptors Targeting B-cell Maturation Antigen AU DIV 2021202158 Pending
NIAID E-135-2010-0-US-37 GENETICALLY STABLE LIVE ATTENUATED RESPIRATORY SYNCYTIAL VIRUS VACCINE AND ITS PRODUCTION US CON 17/224,819 Abandoned
NIAID E-213-2021-2-US-05 Aromatic Ring Substituted Amphiphilic Polymers As Drug Delivery Systems US National Stage 17/282,447 Pending
NCI E-028-2015-1-JP-40 Anti-Mutated Kras T Cell Receptors JP DIV 2021-063092 Issued
NCI E-494-2013-0-HK-25 Methods of Preparing Anti-human Papillomavirus Antigen T Cells HK CN 42021028486.5 Pending
NICHD E-062-2015-0-US-11 CODON-OPTIMIZED REDUCED-SIZE ATP7A CDNA AND USES FOR TREATMENT OF COPPER TRANSPORT DISORDERS US DIV 17/217,961 Pending
NIDCR E-047-2020-0-PCT-02 METHOD FOR BLOCKING UPTAKE OF PROSTATE-SPECIFIC MEMBRANE ANTIGEN (PSMA)-TARGETED RADIONUCLIDES BY EXOCRINE ORGANS PCT PCT PCT/US2021/024647 Expired
NIAID E-131-2020-8-LB-04 Anti-Coronavirus Antibodies And Methods Of Use LB ORD 12153 Pending
NIBIB E-006-2020-0-PCT-02 SYSTEMS AND METHODS FOR MULTIVIEW SUPER-RESOLUTION MICROSCOPY PCT PCT COMB PCT/US2021/024512 Expired
NCI E-008-2019-0-US-05 IMMUNORESPONSIVE CELLS EXPRESSING DOMINANT NEGATIVE FAS AND USES THEREOF US CON 17/214,436 Pending
NCI E-266-2011-0-IL-57 T Cell Receptors Recognizing HLA-A1-or HLA-CW7- Restricted Mage IL DIV 281806 Issued
NCI E-097-2021-0-US-01 FLUOROGENIC HEPTAMETHINE NORCYANINES US 63/165,511 Abandoned
NCI E-065-2021-0-US-01 BICISTRONIC CHIMERIC ANTIGEN RECEPTORS DESIGNED TO REDUCE RETROVIRAL RECOMBINATION AND USES THEREOF US 63/165,195 Abandoned
NCI E-215-2018-0-US-08 2'-HALOGENATED-4'-THIO-2'-DEOXY-5-AZACYTIDINE ANALOGS AND USE THEREOF US National Stage 17/278,625 Pending
NLM E-107-2010-2-US-32 SELECTIVE OXIDATION OF 5-METHYLCYTOSINE BY TET -FAMILY PROTEINS US CON 17/208,940 Abandoned
NCI E-061-2020-0-CN-05 METHODS OF ISOLATING T-CELLS AND T-CELL RECEPTORS FROM TUMOR BY SINGLE-CELL ANALYSIS FOR IMMUNOTHERAPY CN National Stage 202180022592.5 Pending
NCI E-102-2020-0-CN-05 METHODS OF ISOLATING T CELLS AND T-CELL RECEPTORS FROM PERIPHERAL BLOOD BY SINGLE-CELL ANALYSIS FOR IMMUNOTHERAPY CN National Stage 202180030252.7 Pending
NCATS E-041-2021-0-US-01 RALDH1 Inhibitors For The Immunotherapy Of Hepatocellular Carcinoma US 63/163,299 Expired
NCI E-102-2020-0-PCT-02 METHODS OF ISOLATING T CELLS AND T-CELL RECEPTORS FROM PERIPHERAL BLOOD BY SINGLE-CELL ANALYSIS FOR IMMUNOTHERAPY PCT PCT PCT/US2021/023225 Expired
NCI E-061-2020-0-PCT-02 METHODS OF ISOLATING T-CELLS AND T-CELL RECEPTORS FROM TUMOR BY SINGLE-CELL ANALYSIS FOR IMMUNOTHERAPY PCT PCT PCT/US2021/023240 Expired
NIAID E-220-2018-0-US-03 HIV-1 ENV FUSION PEPTIDE NANOPARTICLE CARRIER CONJUGATES AND THEIR USE US National Stage 17/277,694 12053519 Issued PDF
NCI E-010-2019-0-US-03 Compositions And Methods For Modulation Of LMNA Expression US National Stage 17/277,397 Pending
NCI E-111-2021-0-US-01 CANCER VACCINE AND METHOD OF USE THEREOF US 63/162,990 Abandoned
NHGRI E-146-2020-0-US-01 LAMP1 THERAPY IN THE TREATMENT OF LYSOSOMAL STORAGE DISORDERS US 63/162,723 Abandoned
NCI E-266-2011-0-JP-58 T Cell Receptors Recognizing HLA-A1-or HLA-CW7- Restricted Mage JP DIV 2021-043845 Issued
NIAID E-120-2001-1-CA-05 DEVELOPMENT OF MUTATIONS USEFUL FOR ATTENUATING DENGUE VIRUSES AND CHIMERIC DENGUE VIRUSES CA DIV 3114957 Expired
NCI E-205-2018-0-US-07 BICISTRONIC CHIMERIC ANTIGEN RECEPTORS TARGETING CD19 AND CD20 AND THEIR USES US National Stage 17/276,959 Pending
NCI E-050-2014-0-IN-19 Cancer Immunotherapy by Delivering Class II MHC Antigens Using a VLP-Replicon IN DIV 202118011347 Pending
NIDDK E-101-2020-0-PCT-03 Antibacterial And Antifungal Polyketides From Environmental Amycolatopsis Spp. PCT PCT PCT/US2021/022571 Expired
NCI E-167-2017-0-HK-10 CANCER TREATMENT UTILIZING PRE-EXISTING MICROBIAL IMMUNITY HK EP 62021027359.0 Pending
NCI E-205-2018-0-CN-05 Bicistronic Chimeric Antigen Receptor Constructs Targeting CD19 And CD20 CN National Stage 201980060609.9 Pending
NCI E-131-2018-0-CA-01 COMPOSITIONS AND METHODS FOR TREATING CANCER WITH ANTI-CD123 IMMUNOTHERAPY CA National Stage 3113058 Pending
NIAID E-094-2021-0-US-01 CHIKUNGUNYA VLP PRESENTING PLASMODIUM FALCIPARUM CIRCUMSPOROZOITE PROTEIN EPITOPES AS A MALARIA VACCINE US 63/161,688 Abandoned
NCATS E-039-2021-0-US-01 METHODS AND SYSTEMS FOR SOLID PHASE EXTRACTION US 63/161,851 Abandoned
NIAID E-270-2015-0-US-05 SELF-ASSEMBLING INSECT FERRITIN NANOPARTICLES US DIV 17/202,231 11939356 Issued PDF
NCI E-265-2015-0-EP-19 T CELL RECEPTORS RECOGNIZING HLA-CW8 RESTRICTED MUTATED KRAS EP DIV 21162567.8 Pending
NCI E-205-2018-0-EP-06 BICISTRONIC CHIMERIC ANTIGEN RECEPTORS TARGETING CD19 AND CD20 AND THEIR USES EP National Stage 19787115.5 Pending
NCI E-040-2012-0-KR-62 Chimeric Antigen Receptors Targeting B-cell Maturation Antigen KR DIV 2021-7007607 Pending
NCI E-205-2018-0-CA-04 BICISTRONIC CHIMERIC ANTIGEN RECEPTORS TARGETING CD19 AND
CD20 AND THEIR USES 		CA National Stage 3112584 Pending
NCI E-080-2020-0-PCT-02 USE OF ISOVALERYLSPIRAMYCINS AS ANTI-CANCER AGENTS TO INHIBIT METASTASIS PCT PCT PCT/US2021/021831 Expired
NCATS E-026-2016-0-EA-22 Compounds for Improving MRNA Splicing EA DIV 202190500 Issued
NCI E-143-2017-0-US-06 CONFORMATIONAL RESTRICTION OF CYANINE FLUOROPHORES IN FAR-RED AND NEAR-IR RANGE US CON 17/198,004 11707537 Issued PDF
NIDCR E-107-2022-1-US-01 Methods Of Dosing Triphenyl Calcilytic Compounds US 63/159,397 Abandoned
NHLBI E-134-2017-3-US-17 ApoC-llA Mimetic Peptides That Antagonize ApoC-111 US CON 17/195,766 11827690 Issued PDF
NCI E-016-2019-0-US-03 Methods for Decreasing Influenza-Induced Lethality using Gastrin-Releasing Peptide (GRP) Inhibitors or Gastrin-Releasing Peptide Receptor (GRPR) Antagonists US National Stage 17/274,564 Pending
NCI E-075-2020-0-PCT-02 SYSTEMS, METHODS, AND DEVICES FOR EX VIVO ANALYSIS OF RESECTED TISSUE SAMPLES PCT PCT PCT/US2021/021525 Expired